current user: public
If you have questions about the server, please let us know.

Query: 1t0q_B mol:protein length:330 toluene, o-xylene monooxygenase oxygenase subunit, from PDB1018

Results of FFAS03 search in PDB1018
Master-slave alignment(slide right to see more) does not show gaps in the query sequence, use ali links to display alignment between query and templates.
    .   10    .   20    .   30    .   40    .   50    .   60    .   70    .   80    .   90    .  100    .  110    .  120    .  130    .  140    .  150    .  160    .  170    .  180    .  190    .  200    .  210    .  220    .  230    .  240    .  250    .  260    .  270    .  280    .  290    .  300    .  310    .  320    .  330
# Score Template Links and tools%idFirst MSEQQPEALKPLKTWSHLAGNRRRPSEYEVVSTNLHYFTDNPERPWELDSNLPMQTWYKKYCFDSPLKHDDWNAFRDPDQLVYRTYNLLQDGQESYVQGLFDQLNDRGHDQMLTREWVETLARFYTPARYLFHALQMGSVYIHQIAPASTITNCATYETADHLRWLTHTAYRTRELANCYPDVGFGKRERDVWENDPAWQGFRELIEKALIAWDWGEAFTAINLVTKPAVEEALLQQLGSLAQSEGDTLLGLLAQAQKRDAERHRRWSSALVKMALEKEGNREVLQKWVAKWEPLADKAIEAYCSALPDGENAIVEAKSASRYVRQMMGLLast
1 -115.0001t0q_B mol:protein length:330 toluene, o-xylene monooxygenase oxygenase subunit  ali model  100  1MSEQQPEALKPLKTWSHLAGNRRRPSEYEVVSTNLHYFTDNPERPWELDSNLPMQTWYKKYCFDSPLKHDDWNAFRDPDQLVYRTYNLLQDGQESYVQGLFDQLNDRGHDQMLTREWVETLARFYTPARYLFHALQMGSVYIHQIAPASTITNCATYETADHLRWLTHTAYRTRELANCYPDVGFGKRERDVWENDPAWQGFRELIEKALIAWDWGEAFTAINLVTKPAVEEALLQQLGSLAQSEGDTLLGLLAQAQKRDAERHRRWSSALVKMALEKEGNREVLQKWVAKWEPLADKAIEAYCSALPDGENAIVEAKSASRYVRQMMGL 330
2 -102.0003dhg_B mol:protein length:327 toluene 4-monooxygenase hydroxylase beta subunit  ali model follow..  56  1...MSFESKKPMRTWSHLAEMRKKPSEYDIVSRKLHYSTNNPDSPWELSPDSPMNLWYKQYRNASPLKHDNWDAFTDPDQLVYRTYNLMQDGQESYVQSLFDQFNEREHDQMVREGWEHTMARCYSPLRYLFHCLQMSSAYVQQMAPASTISNCCILQTADSLRWLTHTAYRTHELSLTYPDAGLGEHERELWEKEPGWQGLRELMEKQLTAFDWGEAFVSLNLVVKPMIVESIFKPLQQQAWENNDTLLPLLIDSQLKDAERHSRWSKALVKHALENPDNHAVIEGWIEKWRPLADRAAEAYLSMLSSDILPAQYLERSTSLRASILTV 327
3 -89.1002inn_C mol:protein length:333 Phenol hydroxylase component phL  ali model follow..  21  1MSEIKTNSVEPIRTYGHIARRDKPATRYQEASYDIEAKTNFH---YRPQWDSEHTLND---PTRTAIRMEDWCAVSDPRQFYYGAYVGNRAKMQESAETSFGFCEKRNLLTRLSEETQKQLLRLLVPLRHVELGANMNNAKIAGDATATTVSQMHIYTGMDRLGIGQYLSRIALMIDGSTGAAL--DESKAYWMDDEMWQPMRKLVEDTLVVDDWFELTLVQNILIDGMMYPLVYDKMDQWFESQGAEDVSMLTEFMRDWYKESLRWTNAMMKAVAGEETNRELLQKWIDHWEPQAYEALKPLAEASVG-IDGLNEARAELSARLKKFEL 326
4 -78.9001fyz_C mol:protein length:389 METHANE MONOOXYGENASE COMPONENT A, BETA CHAIN  ali model follow..  14  21LKALPEAPLDGNNKMGYFTPRWKRLTEYEALTVYAQPNADWIAGDWTQKFHGGRPSWG---NETTELRTVDWFKHRDPLRRWHAPYVKDKAEEWRYTDRFLQGYSADGQIRAMNPTWRDFINRYWGAFLFNEYGLFNAHSQGAREALSDVTRVSLAFWGFDKIDIAQMIQLERGFLAKIVPGFDSTAVPKAEWTNGEVYKSARLAVEGLWQEFDWNESAFSVHAVYDALFGQFVRREFQRLAPRFGDNLTPFFINQAQTYFQIAKQGVQDLYYNCLGDDYNRTVMRNWTGKWLEPTIAALRDFMGLFAKLEEITASLYRVVDDWIEDYAS 369
5 -78.7001mmo_B mol:protein length:384 METHANE MONOOXYGENASE HYDROLASE (BETA CHAIN)  ali model follow..  14  16LKALPEAPLDGNNKMGYFVPRWKRLTEYEALTVYAQPNADWIAGGWTQKFHGGRPSWG---NETTELRTVDWFKHRDPLRRWHAPYVKDKAEEWRYTDRFLQGYSADGQIRAMNPTWRSSCNRYWGAFLFNEYGLFNAHSQGAREALSDVTRVSLAFWGFDKIDIAQMIQLERGFLAKIVPGFDSTAVPKAEWTNGEVYKSARLAVEGLWQEFDWNESAFSVHAVYDALFGQFVRREFQRLAPRFGDNLTPFFINQAQTYFQIAKQGVQDLYYNCLGDDYNRTVMRNWTGKWLEPTIAALRDFMGLFAKLPAGTTDKEEITASLYRVV.. 355
6 -77.8001mhy_B mol:protein length:395 METHANE MONOOXYGENASE HYDROXYLASE  ali model follow..  17  26..AVPDHALDTQRYHYFIQPRWKPLSEYEQLSCYAQPNPDLDWGDWTQKFHGGRPSWG---NESTELRTTDWYRHRDPARRWHHPYVKDKSEEARYTQRFLAAYSSEGSIRTIDPYWREILNKYFGALLYSEYGLFNAHSSVGRDCLSDTIRQTAVFAALDKVDNAQMIQMERLFIAKLVPGFDSTDVPKKIWTTDPIYSGARATVQEIWQGQDWNEILWAGHAVYDATFGQFARREFQRLATVYGDTLTPFFTAQSQTYFQTTRGAIDDLFVYCLANDHNRTFLNAWTEHYLASSVAALKDFVGLYAKVEKVAGAFGDWKIDYADKIGF 378
7 -76.9001t0q_A mol:protein length:498 toluene, o-xylene monooxygenase oxygenase subunit  ali model follow..  13  3.....................MLKREDWYDLTRTTN---------WTPKYVTENELFPEEMSGARGISMEAWEKYDEPYKITYPEYVSIQREKDSGAYSIKAALERDGFVDRADPGWVSTMQLHFGAIALEEYAASTAEARMARFAKAPGNRNMATFGMMDENRHGQIQLYFPYANVKRSRKWD--WAHKAIHTNEWAAIAARSFFDDMMMTRDSVAVSIMLTFAFETGFTNMQFLGLAADAAEAGDHTFASLISSIQTDESRHAQQGGPSLKILVENG-KKDEAQQMVDVAIWRSWKLFSVLTGPIMDYYTPLESRNQSFKEFLLDLGL 311
8 -76.6003dhg_A mol:protein length:500 toluene 4-monooxygenase hydroxylase alpha subunit  ali model follow..  14  2....................AMHPRKDWYELTRATN---------WTPSYVTEEQLFPERMSGHMGIPLEKWESYDEPYKTSYPEYVSIQREKDAGAYSVKAALERAKIYENSDPGWISTLKSHYGAIAVGEYAAVTGEGRMARFSKAPGNRNMATFGMMDELRHGQLQLFFPHEYCKKDRQFD--WAWRAYHSNEWAAIAAKHFFDDIITGRDAISVAIMLTFSFETGFTNMQFLGLAADAAEAGDYTFANLISSIQTDESRHAQQGGPALQLLIENG-KREEAQKKVDMAIWRAWRLFAVLTGPVMDYYTPLEDRSQSFKEFLIDLGL 311
9 -70.4002inn_A mol:protein length:511 Phenol hydroxylase component phN  ali model follow..  16  1MVSKN--------------KKLNLKDKYQYLTRDMA---------WEPTYQDKKDIFPE--EDFEGIKITDWSQWEDPFRLTMDAYWKYQAEKEKKLYAIFDAFAQNNGHQNIDARYVNALKLFISGISPLEHAAFQGYSKVGRQFSGAGARVACQMQAIDELRHSQTQQHAMSHYNKHFNGLH---DGPHMHDRVWYLSVPKSFFDDARSAGPF-EFLTAISFSFEYVLTNLLFVPFMSGAAYNGDMATVTFGFSAQSDEARHMTLGLEVIKFILEQEDNVPIVQRWIDKWFWRGFRLLSLVSMMMDYMEVYYEQNGGALFKDLERYGI 315
10 -69.7001mhy_D mol:protein length:521 METHANE MONOOXYGENASE HYDROXYLASE  ali model follow..  14  2................AISLATKAATNRAPVGVEPQVHKWLQSFNWDFKEN----------RTKYPTKYHMANETKEQFKVIAKEYARMEAAKDERQFGTLDGLTRLGAGNKVHPRWGETMKVISNFLEVGEYNAIAASAMLWDSATAAEQKNGYLAQVLDEIRHTHQCAFINHYYSKHYHDPAGHNDARRTRAIGPLWKGMKRVFADGFISGDAVECSVNLQLVGEACFTNPLIVAVTEWASANGDEITPTVFLSVETDELRHMANGYQTVVSIANDPASAKFLNTDLNNAFWTQQKYFTPVLGYLFEYGSKFKVEPGIWIGRLGKYGV 321
11 -69.4001fyz_A mol:protein length:527 METHANE MONOOXYGENASE COMPONENT A, ALPHA CHAIN  ali model follow..  13  4........................STATKAATDALAANRAPTSVNFNWDFK--------NNRTKYATKYKMANETKEQFKLIAKEYARMEAVKDERQGSLQDALTRLNAGVRVHPKWNETMKVVSNFLEVGEYNAIAATGMLWDSAQAAEQKNGYLAQVLDEIRHTHQCAYVNYYFAKNGQDPAGHNDARRTRTIGPLWKGMKRVFSDGFISGDAVECSLNLQLVGEACFTNPLIVAVTEWAAANGDEITPTVFLSIETDELRHMANGYQTVVSIANDPASAKYLNTDLNNAFWTQQKYFTPVLGMLFEYGSKFKVEPGIWIGRLGKYGV 326
12 -35.8005ux2_A mol:protein length:234 Aldehyde decarbonylase  ali model follow..  9  4.............................................................................................................LDFASAAYREAYSRINGVVIVGEGLANRHFQMLARRIPA--DRDELQRLGRMEGDHASAFVGCGRNLGVVADLP----------LARRLFQPLHDLFKRHDHDGNRAECLVIQGLIVECFAVAAY-----RHYLPVADAYARPITAAVMNDESEHLDYAETWLQRHFDQVKASAVVVEALPLTLAMLQSLAADMRQIGMDPVETLASFSELFREALESVGF 209
13 -34.9005uxg_A mol:protein length:220 aldehyde deformylating oxygenase  ali model follow..  8  5.............................................................................................................WFSTPQEIREGIKYLSAHFYPASIMDRWKILKKLSFEKAKIIANYSLQQVIEEIEHFDFFNEYFKEDPLTTVR-----------LPPSYIKLFDGLVEDFQSSRWRENIATRFHMITEGVLATVGLKILNETSRKYNLLKFNEGIKRIIEDEARHVSFGLSLIEDKEYAVKR---VEELFPLAVQIVKEGKDKIEPLGYSIQELVNLMEELKKARINKI.. 209
14 -34.3004kvr_A mol:protein length:244 Aldehyde decarbonylase  ali model follow..  11  25..............................................................................................................DFTSDRYKDAYSRINAIYIEGEQEAHDNYIAIGTLLPD--HVEELKRLAKMEMRHKKGFTACGKNLGVEADMD----------FAREFFAPLRDNFQTALGQGKTPTCLLIQALLIEAFAISAY-----HTYIPVSDPFARKITEGVVKDEYTHLNYGEAWLKANLESCRELEANRENLPLIRRMLDQVAGDAAVLQMDKEDLIEDFLIAYQESLTEIGF 229
15 -34.2004quw_A mol:protein length:231 Aldehyde decarbonylase  ali model follow..  9  1....................................................................................................MPQLEASLELDFQSESYKDAYSRINAIVIEGEQEAFDNYNRLAEMLPD--QRDELHKLAKMEQRHMKGFMACGKNLSVTPDMG----------FAQKFFERLHENFKAAAAEGKVVTCLLIQSLIIECFAIAAY-----NIYIPVADAFARKITEGVVRDEYLHRNFGEEWLKANFDASKAEEANRQNLPLVWLMLNEVADDARELGMERESLVEDFMIAYGEALENIGF 215
16 -34.2005uwz_A mol:protein length:243 Aldehyde decarbonylase  ali model follow..  8  3.....................................................................................................RTAPSSAALDYRSDTYRDAYSRINAIVLEGEREAHANYLTLAEMLPD--HAEALKKLAAMENRHFKGFQSCARNLEVTPDDP----------FARAYFEQLDGNFQQAAAEGDLTTCMVIQALIIECFAIAAY-----NVYIPVADAFARKVTEGVVKDEYTHLNFGQQWLKERFVTVREERANAQNLPIVWRMLNAVEADTEVLQMDKEAIVEDFMIAYGEALGDIGF 216
17 -34.0004z5s_A mol:protein length:231 Aldehyde decarbonylase  ali model follow..  7  1....................................................................................................MPELAVRTEFDYSSEIYKDAYSRINAIVIEGEQEAYSNYLQMAELLPE--DKEELTRLAKMENRHKKGFQACGNNLQVNPDMP----------YAQEFFAGLHGNFQHAFSEGKVVTCLLIQALIIEAFAIAAY-----NIYIPVADDFARKITEGVVKDEYTHLNYGEEWLKANFATAKEEQANKENLPLVWKMLNQVQGDAKVLGMEKEALVEDFMISYGEALSNIGF 215
18 -33.6005uxi_A mol:protein length:234 Aldehyde decarbonylase  ali model follow..  6  1...................................................................................................MQQLTDQSKELDFKSETYKDAYSRINAIVIEGEQEAHENYITLAQLLPE--SHDELIRLSKMESRHKKGFEACGRNLAVTPDLQ----------FAKEFFSGLHQNFQTAAAEGKVVTCLLIQSLIIECFAIAAY-----NIYIPVADDFARKITEGVVKEEYSHLNFGEVWLKEHFAESKAELANRQNLPIVWKMLNQVEGDAHTMAMEKDALVEDFMIQYGEALSNIGF 216
19 -33.3004pgi_A mol:protein length:250 Aldehyde decarbonylase  ali model follow..  12  25..............................................................................................................DFTSDRYKDAYSRINAIVIEGEQEAHDNYIAIGTLLPD--HVEELKRLAKMEMRHKKGFTACGKNLGVKADMD----------FAREFFAPLRDNFQTALGQGKTPTCLLIQALLIEAFAISAY-----HTYIPVSDPFARKITEGVVKDEYTHLNYGEAWLKANLESCREEEANRENLPLIRRMADQVAGDAAVLQMDKEDLIEDFLIAYQESLTEIGF 229
20 -31.2005k52_A mol:protein length:265 Aldehyde decarbonylase  ali model follow..  9  37..............................................................................................................DYQSETYKDAYSRINAIVIEGEDEAANNYVRLAELMPE--QSEELASLAKMEARHKKGFTACGKNLNVTPDMD----------FAKKFFSDLHGNFQVAAAAGNIVTCLLIQALIIEAFAISAY-----NVYIPHADDFARKITENVVKDEYLHLNFGEQWLKANFESAKDERANRENLAIVWRMLDEVAGDALVLGMEKEALMEDFTIAYQEALQNIGF 241
21 -30.8004hr0_A mol:protein length:316 Ribonuleotide reductase small subunit  ali model follow..  9  32......................................................................................YEKAKRNGKWNPADIDFSQDQKDFASLTSEEKISALPLVAGFSAGEEAVTLDILPMAHALARQEDVLFLTTFMHDEAKHVEMFSRWQQAVGIGQMDLSVFHNDHYKRIFYEALPEAMNRLYADDSPEAVIRAATVYNMIVEGTLAESGYYTFRQIYKKAG-PGLLQGIDYLNMDEGRHIQFGIYTIQRIVEDERYYELFIRYMDELWPHVIGYVDYLTELEIDYDLLRHYVIKQFNLRKKQISR 293
22 -30.7005k53_A mol:protein length:262 aldehyde deformylating oxygenase  ali model follow..  7  37..............................................................................................................DFQTETYKDAYSRINAIVIEGEQEAHDNYLTLAELLADK--KAELVGLSKMENRHMKGFQACGRNLKVTPDMA----------FAKQFFSELHKNFQTAAAQGQIVTCLLIQSLIIECFAIAAY-----NIYIPVADDFARKITEGVVKEEYSHLNFGEVWLQAHFEESKAEAANRQNLPIIWKLLNAVADDARVLGMEKDALIEDFMIAYGEALGNIGF 241
23 -28.8003ee4_A mol:protein length:323 Probable ribonucleoside-diphosphate reductase  ali model follow..  9  28................................................................AGGNAKFW----HPAD--------------------IDFTRDRADWEKLSDDERDYATRLCTQFIAGEEAVTEDIQPFMSAMRAEADEMYLTQFAFEEAKHTQVFRMWLDAVGISEDLHRYLDDLPAY-IFYAELPECLNALSADPSPAAQVRASVTYNHIVEGMLALTGYYAWHKICVERA-PGMQELVRRIGDDERRHMAWGTFTCRRHVADDANWTVFETRMNELIPLALRLIEEGFALYGSKDDFLQYSTDKGMRRFGTISN 282
24 -27.9004mud_A mol:protein length:235 Ring oxydation complex/ phenylacetic acid degradation related protein  ali model follow..  10  3........................................................................................................QKLRSVKEVPQDLTNTLVNIIELRADFELAMVEQYSPWLVNAPTVDSRLFVAKLVSDELNHGWQLVRLLEEFKVKDVIERISNARLGIHKLEVSNLPLFNWED-----------VIAFTFLVDGAGLYQL-----KILKDCSFEPLSTLASSMIKEEESHIFFSQNELRNYQNKNRMQGAINFWFPRAVEMLHMTWSLNETHLRDLNDLINGYIKTTNEELKKCGY 219
25 -27.3003pvr_A mol:protein length:311 Phenylacetic acid degradation protein paaA  ali model follow..  8  1........................................................................................MRSTQEERFEQRIAQETAIEPQDWMPDAYRKTLIRQIGQHAHSEIVGMLPEGNWITRAPTLRRKAILLAKVQDEAGHGLYLYSAAETLGCAREDIYQKMLDGRMKYSSIFNYPTLSWAD-----------IGVIGWLVDGAAIVNQ-----VALCRTSYGPYARAMVKICKEESFHQRQGFEACMALAQGEAQKQMLQDAINRFWWPALMMFGP-----FTNDELRQRFVDNTVPQVEMLGM 240
26 -26.8004iit_A mol:protein length:320 Phenylacetate-CoA oxygenase subunit PaaA  ali model follow..  8  6..........................................................................................STEEQRFDQRIAQETAIEPQDWMPDAYRKTLIRQIGQHAHSEIVGMLPEGNWITRAPTLRRKAILLAKVQDEAGHGLYLYSAAETLGCAREDLYQKMLDGQMKYSSIFNYPTLSWAD-----------IGVIGWLVDGAAIVNQ-----VALCRTSYGPYARAMVKICKEESFHQRQGFEACMALAQNEAQRQMLQDAINRFWWPALMMFGPNDD--HSNDELRQRFVDNTVPQVEILGM 243
27 -22.4004bmo_A mol:protein length:322 RIBONUCLEOSIDE-DIPHOSPHATE REDUCTASE SUBUNIT BETA  ali model follow..  9  1..................................................................MRAVNWNKKEDDF--SLMFWKQNIAQ----TEEEIAVSSDKNTWVQLSKEEQIAYKRVLGGLTLLDTKQGEGMPLVLVHLENLQAKSVLAFMGAMEEVHAKSYSHIFTTLATEEEIDDIFDWVDNHPLLEKKAGIITSYYRRLLKPEV-LYMAMVASVFLESYLFYSGFFYPLYLAGQGKLTASGEIINLIIRDESIHGVFVGILAQQIFAELSAQKETQELLMELYEIEMAYTEEIYTSIGLVEDVNRFVRYNANKGLMNLGL 270
28 -22.1002vux_A mol:protein length:326 RIBONUCLEOSIDE-DIPHOSPHATE REDUCTASE SUBUNIT M2 B  ali model follow..  6  1MSSGVDLGTENLYFQSMSDTNESEIKSNEEPLLRKSSRR----------FVIFPIQYPDIWKMYKQAQASFW------------------------TAEEVDLSKDLPHWNKLKADEKYFISHILAFFAASDGIVNELVERFSQEVQVPEARCFYGFQILIENVHSEMYSLLIDTYIRDPKKRE--FLFNAIETMPYVKKKADWALRWIADRKSTFGERVVAFAAVEGVFFSGSFAAIFWLKKRGLMPGLTFSNELISRDEGLHCDFACLMFQYLVNKPS-EERVREIIVDAVKIEQEFLTEALPIGMNCILMKQYIEFVADRLLVELGF 297
29 -22.0002o1z_A mol:protein length:311 Ribonucleotide Reductase Subunit R2  ali model follow..  8  46.......................................................LYPDVWDFYKKAEASFW------------------------TAEEIDLSSDLKDFEKLNDNEKHFIKHVLAFFAASDGIVLENLAKFLRQVKITEAKKFYAFQIAVENIHSETYSLLIDNYIKDEKERMNLFHAIE---NIPAVKNKALWAAKWINDTNSFAERIVANACVEGILFSGSFCAIFWFKKQNKLHGLTFSNELISRDEGLHTDFNCLIYSLLENKLPE-EVVQNIVKEAVEVERSFICESLPIGMNSRLMSQYIEFVADRLLECLGS 296
30 -21.9003vpm_A mol:protein length:286 Ribonucleoside-diphosphate reductase subunit M2  ali model follow..  7  22.......................................................EYHDIWQMYKKAEASFW------------------------TAEAVDLSKDIQHWESLKPEERYFISHVLAFFAASDGIVNENVERFSQEVQITEARCFYGFQIAMENIHSEMYSLLIDTYIKDPKEREFLFNAIE--TMPCVKKKADWALRWIGDKEATYGERVVAFAAVEGIFFSGSFASIFWLKKRGLMPGLTFSNELISRDEGLHCDFACLMFKHLVHKP-SEERVREIIINAVRIEQEFLTEALPIGMNCTLMKQYIEFVADRLMLELGF 273
31 -21.5003pvr_B mol:protein length:259 Phenylacetic acid degradation protein paaC  ali model follow..  11  1................................................................................................................MGSSGSNQLTAYTLRLGDNCLVLSQRLGEWCGHAPELEIDLALANIGLDLLGQARNFLSYAAELAGEGDEDTLAFTRDE--------RQFSNLLLVEQPNGNFAD------TIARQYFIDAWHVALFTRLMESRDPQLAAISAKAIKEARYHLRFSRGWLERLGNGDVSGQKMQQAINKLWRFTAELFDAEEGIAVDPRTLRAAWEAEVFAGINEATL 213
32 -21.2002rcc_A mol:protein length:346 Ribonucleoside-diphosphate reductase subunit beta  ali model follow..  9  37.......................................................RFSWAYPLYKNMLANFW------------------------TPFEINMSHDAKQFPTLTETEQEAFKKIIGLLAFLDSVQTDYSMRAAEYLTDSSLAALMSVLSFQEVVHNQSYSYVLSSLVPKATQDEIFEYWKHDDVLKERNEFIIDGYEKF-PTPKTFLESIVYDVILEGLNFYSGFAFFYNLARNQKMVSTSTMINYINRDEQLHVYLFTNIFKELLVEFPEKTFVKTTLMKAADLEKDWFRYIIGPGINPEDMETYISFIANKRAVQLGM 298
33 -21.2002jcd_A mol:protein length:345 N-OXIDASE  ali model follow..  10  10MREEQPHLATTWAARGWVEEEGIGSATLGRLV--------------------------RAWPRRAAVVNKDEWADYDTLVPDYPL--------------EIVPFAEHPLFLAAEPHQRQRVLTYNERVIATEQLIALVMHGVFPGSDDPLIRKSVQQAIVDESFHTYMHMLAIDRTRELRK------SERPPQPELVTYRRLRRVLADMPEQWERDIAVLVWGAVAETCINALLALLARDATI---QPMHSLITTLHLRDETAHGSIVVEVVRELYANEQQRRALVRCLPIALEFAEQDLSALLLELNAAGTRLVRDFSGARKMVEQLGL 325
34 -21.1002uw2_A mol:protein length:332 RIBONUCLEOSIDE-DIPHOSPHATE REDUCTASE M2 SUBUNIT  ali model follow..  7  29.......................................................EYHDIWQMYKKAEASFW------------------------TAEEVDLSKDIQHWESLKPEERYFISHVLAFFAASDGIVNENVERFSQEVQITEARCFYGFQIAMENIHSEMYSLLIDTYIKDPKEREFLFNAIE--TMPCVKKKADWALRWIGDKEATYGERVVAFAAVEGIFFSGSFASIFWLKKRGPMPGLTFSNELISRDEGLHCDFACLMFKHLVHKP-SEERVREIIINAVRIEQEFLTEALPIGMNCTLMKQYIEFVADRLMLELGF 280
35 -20.8004iit_C mol:protein length:251 Phenylacetate-CoA oxygenase subunit PaaC  ali model follow..  13  2...................................................................................................................NNPNPVATYALRLGDNGLVLAQRLGAWCGHAPELEIDLALANIGLDLLGQARNFLSYAAELNGCGDEDTLAFGRDE--------RQYSNLLLVEQPNGNFAD------TIARQFFIDVWHVALYSRLVNSRDAQLAAIAAKGLKEVRYHLRFSRGWLERLGNGELSNRKMQQAVDNLWRFTGELFLA-QGIAVDPRELQAEWQSAVHTALLDSGL 211
36 -20.7003n37_A mol:protein length:319 Ribonucleoside-diphosphate reductase 2 subunit beta  ali model follow..  10  2..............................................................KLSRISAINWNKISDD--KDLEVWNRLTSN----LPEKVPLSNDIPAWQTLTVVEQQLTMRVFTGLTLLDTLQNVIAPSLMPDALTPHEEAVLSNISFMEAVHARSYSSIFSTLCQTKDVDAAYAWSEE----NAPLQRKAQIIQQHYRGDDPLKKKIA-SVFLESFLFYSGFWLPMYFSSRGKLTNTADLIRLIIRDEAVHGYYIGYKYQKNMEKISLKSFAFDLLLELYDNELQYTDELYAETPWADDVKAFLCYNANKALMNLGY 267
37 -20.5001uzr_A mol:protein length:296 RIBONUCLEOTIDE REDUCTASE R2-2 SMALL SUBUNIT  ali model follow..  9  15......................................................................NWNRLQDE--KDAEVWDRLTGN----LPEKVPVSNDIPSWGTLTAGEKQLTMRVFTGLTMLDTIQGTVAVSLIPDALTPHEEAVLTNIAFMESVHAKSYSQIFSTLCSTAEIDDAFRWSE----ENRNLQRKAEIVLQSYRGDEPLKRKVA-STLLESFLFYSGFYLPMYWSSRAKLTNTADMIRLIIRDEAVHGYYIGYKFQRGLALVDDKDYTYELLFELYDNEVEYTQDLYDEVGLTEDVKKFLRYNANKALMNLGY 272
38 -20.2004n83_A mol:protein length:319 Ribonucleoside-diphosphate reductase subunit beta  ali model follow..  9  2...............................................................QTYYKAINWNAIEDVI--DKSTWEKLTEQ----LDTRIPLSNDLDDWRKLSHKEKDLVGKVFGGLTLLDTLQSESVDALRKDVRTAHEEAVFNNIQFMESVHAKSYSSIFSTLNTKSEIDEIFAWTN----TNPYLQKKAEIINEIYLNGTALEKKIA-SVFLETFLFYSGFFTPLYYLGNNKLANVAEIIKLIIRDESVHGTYIGYKFQLAFNELPEKEWMYDLLYTLYENEEGYTESLYDTVGWTEEVKTFLRYNANKALMNLGQ 266
39 -20.0006cwo_A mol:protein length:344 Ribonucleotide reductase  ali model follow..  8  28.......................................................EYPEVLQFTEAINKAYW----VHTEVDFTA-------------------DTQDFHAHLSLAEKTAVKNSLLAIAQIEVAVKSFWGNIYEHFPKPEFNGLGSTFAECEFRHSEAYSRLLEVLGYNDEFEKLLDVPVIRRRVDYLSNVLKDTKSQ--DNRKYMVSLILFSILIENVSLFSQFAILLSFTRFKG-KNVSNIIAWTSIDEQIHANGGIYIINKIREEFPDRETVKDSIAVESDILDWIFEEGEIESIKKGDLVNFMKFRIDESLKQINI 288
40 -19.9006ebo_A mol:protein length:355 Ribonucleoside-diphosphate reductase, beta subunit  ali model follow..  10  1MGSSSSGLVPRGSTKNYYDRSVSPVEYAYFDQSQNMRAINWNKI-----------VDEKDLEVWNRVTQNFW------------------------LPENIPVSNDLPSWNELDDDWQQLITRTFTGLTLLDTVQSSIDVAQIKNSLTEQEQVIYANFAFMVGVHARSYGTIFSTLCTSEQIEEAHEWVV----DNEALQARPKALIPFYTADDPLKSKIA-AALMPGFLLYGGFYLPFYLSARGKLPNTSDIIRLILRDKVIHNFYSGYKYQLKVAKLSPKQFVFDLLDKMIGLEKTYLHQLYDGFGLADEAIRFSLYNAGKFLQNLGY 297
41 -19.9001kgn_A mol:protein length:329 Ribonucleotide reductase protein R2F  ali model follow..  10  25.......................................................PDEKDLEVWDRLTGNFW------------------------LPEKIPVSNDIQSWNKMTPQEQLATMRVFTGLTLLDTIQGTVAISLLPDAETMHEEAVYTNIAFMESVHAKSYSNIFMTLASTPQINEAFRWSE----ENENLQRKAKIIMSYYNGDDPLKKKVA-STLLESFLFYSGFYLPMYLSSRAKLTNTADIIRLIIRDESVHGYYIGYKYQQGVKKLSEKAYTFDLMYDLYENEIEYTEDIYDDLGWTEDVKRFLRYNANKALNNLGY 277
42 -19.6003per_A mol:protein length:481 Benzoyl-CoA oxygenase component B  ali model follow..  12  1MINYSER-IPNNVNLNENKTLQRALEQWQPSFLN-----------WWDDMGPENSSNYDVYLRAVSVDPKGWADFGYVKMHDYR-WGIFLAPQEGEKKITFGEHKGQDVWQEVPGEYRSTLRRIIVTQGDTEPASVEQQRHLGLTAPSLYDLRNLFQVNVEEGRHLWAMVYLLHAHFGRDGREEGEALLERRSGDEDNPRILTAFNEKT---PDWLS-FFMFTFITDRDGKFQL-----ASLAESAFDPLARTCKFMLTEEAHHLFVGESGIARVIQRTCEVPTLQKYLNFHYSVTSDLYGAEISSNAATEEKIGDDHKLQNSEYEVMDV 340
43 -19.4001jk0_B mol:protein length:345 ribonucleoside-diphosphate reductase small chain 2  ali model follow..  6  41.......................................................KYHEIWAAYKKVEASFW------------------------TAEEIELAKDTEDFQKLTDDQKTYIGNLLALSISSDNLVNKYLINFSAQLQNPEGKSFYGFQIMMENIYSEVYSMMVDAFFKDPKNIPLFKEIAN---LPEVKHKAAFIERWISNDDSLYAERLVAFAAKEGIFQAGNYASMFWLTDKKIMPGLAMANRNICRDRGAYTDFSCLLFAHLRTKPNP-KIIEKIITEAVEIEKEYYSNSLPFGMDLKSIHTYIEFVADGLLQGFGN 291
44 -19.3006gp2_A mol:protein length:345 Ribonucleoside-diphosphate reductase beta chain  ali model follow..  12  29...............................................................KGKMRSVNWNVVNDE--KDLEVWNRITQN----LPEKIPVSNDLTSWRTLTPEWQELITRTFTGLTLLDTIQATVDVAQVPNSLTDHEQVIYTNFAFMVAVHARSFGSIFSTLCSSEQIEEAHEWVI----NTETLQERAKALIPYYVNDDPLKSKVA-AALMPGFLLYGGFYLPFYLSARGKLPNTSDIIRLILRDKVIHNYYSGYKYQKKVAKLSPKEFVFKLLYELIDLEKAYLKELYEDFGLADDAIRFSVYNAGKFLQNLGY 293
45 -19.1001r2f_A mol:protein length:319 PROTEIN (RIBONUCLEOTIDE REDUCTASE R2)  ali model follow..  11  10......................................................................NWNKIQDDK--DLEVWNRLTSN----LPEKVPLSNDIPAWQTLSAAEQQLTIRVFTGLTLLDTIQNIAAPSLMADAITPHEEAVLSNISFMEAVHARSYSSIFSTLCQTKEVDAAYAWSE----ENPPLQRKAQIILAHYVSDEPLKKKIA-SVFLESFLFYSGFWLPMYFSSRGKLTNTADLIRLIIRDEAVHGYYIGYKYQIALQKLSAKLFALDLLMELYDNEIRYTEALYAETGWVNDVKAFLCYNANKALMNLGY 267
46 -18.9002p1i_A mol:protein length:349 Ribonucleotide reductase, small chain  ali model follow..  7  47.......................................................MYPEVWNFYKKAEASFW------------------------TAEEIDLSSDLKDFEKLNVNEKHFIKHVLAFFAASDGIVLENASKFLREVEIIEAKKFYSFQIAVENIHSETYSLLIDNYIKDEKERLNLFHAIE---NIPAIKNKALWAAKWINDTNSFAERIVANACVEGILFSGSFCAIFWFKKQNKLHGLTFSNELISRDEGLHTDFNCLIYSLLENKLPENVVIVKEAVEVERSFICESLPCDLIGMNSRLMSQYIEFVADRLLECLGC 297
47 -18.8005hyg_A mol:protein length:317 Uncharacterized protein  ali model follow..  10  12....................................................................VGNWHR-RAAVKREEPDVYALFDPGRPDFREDMIPFRGHPIWERLSDETRSRLLAYNRNTVLIEQRIALVIGGAYPGLGGQQLELAVAQAMVDEQYHTLMHINGSAVTRRMRR----SDFSDRVLPDSHITTIHQEHLDRCEEPWQRSLTTLGFATVAEISINAYLDLLADDQEI---QVVNSTTVKLHNRDEYCHASISGEMMKQVYEPADRRRFLLEKVVAGLEVAFEGVPGWEKAAAEVREALVQDHSGIHTLLTEMDV 295
48 -18.7003hf1_A mol:protein length:351 Ribonucleoside-diphosphate reductase subunit M2 B  ali model follow..  5  48.......................................................QYPDIWKMYKQAQASFW------------------------TAEEVDLSKDLPHWNKLKADEKYFISHILAFFAASDGIVNENVERFSQEVQVPEARCFYGFQILIENVHSEMYSLLIDTYIRDPKKREFLFNAIE--TMPYVKKKADWALRWIADRKSTFGERVVAFAAVEGVFFSGSFAAIFWLKKRGLMPGLTFSNELISRDEGLHCDFACLMFQYLVNKP-SEERVREIIVDAVKIEQEFLTEALPIGMNCILMKQYIEFVADRLLVELGF 299
49 -18.7001h0n_A mol:protein length:390 RIBONUCLEOSIDE-DIPHOSPHATE REDUCTASE  ali model follow..  7  11IADQQQLQLSPLKRLTLADKENTPPTLSSTRVLASKAARRIFQDSAELESKAPTNEYHDIWQMYKKAEASFW------------------------TAEEVDLSKDIQHWEALKPDERHFISHVLAFFAASDGIVNENVERFSQEVQVTEARCFYGFQIAMENIHSEMYSLLIDTYIKDPKEREYLFNAIE--TMPCVKKKADWALRWIGDKEATYGERVVAFAAVEGIFFSGSFASIFWLKKRGLMPGLTFSNELISRDEGLHCDFACLMFKHLVHKP-AEQRVREIITNAVRIEQEFLTEALPIGMNCTLMKQYIEFVADRLMLELGF 338
50 -18.2004d8f_A mol:protein length:366 Ribonucleoside-diphosphate reductase subunit beta  ali model follow..  8  49.......................................................KYKWAWEHYLNGCANNWLPTEIPMGKDIELWKS----------------------DRLSEDERRVILLNLGFFSTAESLVGNIVLAIFKHVTNPEARQYLLRQAFEEAVHTHTFLYICESLGLDEKEIFNAYNERAAIKAKDDF--QMEITGKVLDPQEFVKNLVGYYIIMEGIFFYSGFVMILSFHRQNKMIGIGEQYQYILRDETIHLNFGIDLINGIKEENPEQQEIVELIKRAVDLEIEYAQDCLPLGLRASMFIDYVQHIADRRLERIGL 319
51 -17.4004dr0_A mol:protein length:350 Ribonucleoside-diphosphate reductase subunit beta  ali model follow..  8  24......................................................................NWSKHEDDF--TQMFYNQNVKQ----LPEEIALNGDLLTWKYLGKNEQDTYMKVLAGLTLLDQGNTGMPIVAEHVDGHQRKAVLNFMAMMENAVHAKSYSNIFMTLAPTETINEVFEWVKQNKYLQKKAQMIVGLYKAI-DDEISLFKAMVASVYLESFLFYSGFYYPLYFYGQGKLMQSGEIINLILRDEAIHGVYVGLLAQEIYNKQTEREFAIDLLNQLYENELEYTEDLYDQVGLSHDVKKFIRYNANKALMNLGF 288
52 -17.3001pfr_A mol:protein length:340 PROTEIN R2 OF RIBONUCLEOTIDE REDUCTASE  ali model follow..  9  20...............................................................GQPVNVARYDQQKYDI--FEKLIEKQLSF----RPEEVDVSRDRIDYQALPEHEKHIFISNLKYQTLLDSIQGRSNVALLPLISIPELETWVETWAFSETIHSRSYTHIIRNIVNDPSVV-------DDIVTNEQIQKRAEGISSYYDEKKKLYLCLMSVNALEAIRFYVAFACSFAFAERELMEGNAKIIRLIARDEALHLTGTQHMLNLLRSGADDYDLFVQAAQQEKDWADYLFRDGSMIGLNKDILCQYVEYITNIRMQAVGL 321
53 -17.2001jk0_A mol:protein length:419 ribonucleoside-diphosphate reductase small chain 1  ali model follow..  5  106.......................................................KYHEIWQAYKRAEASFW----TAEEIDLSK-------------------DIHDWNNRMNENERFFISRVLAFFAASDGIVNENLVNFSTEVQIPEAKSFYGFQIMIENIHSETYSLLIDTYIKDPKESE--FLFNAIHTIPEIGEKAEWALRWIQDADALFGERLVAFASIEGVFFSGSFASIFWLKKRGMMPGLTFSNELICRDEGLHTDFACLLFAHLKNKPDP-AIVEKIVTEAVEIEQRYFLDALPVALNADLMNQYVEFVADRLLVAFGN 358
54 -16.9001za0_A mol:protein length:275 POSSIBLE ACYL-[ACYL-CARRIER PROTEIN] DESATURASE DESA2 (ACYL-[ACP] DESATURASE) (STEAROYL-ACP DESATURASE)  ali model follow..  12  28...................................................................TEDIWFAH---------DYVPFDQGENFAFLGGRD-------WDPSQSTLPRTITDACEILLILKDNLAGHHRELVEFILEDWWGRWLGRWTAEEHLHAIALREYLVVTREVDPVANEDVR-------------VQHVMKGYRAEKYTQVETLVYMAFYE----RCGAVFCRNLAAQIEEPILAGLIDRIARDEVRHEEFFANLVTHCLDYTRDIAAIAARAADLDVLGADIEDKLQNVADAGIFGKPQLRQLISDRITAWGL 263
55 -16.1001biq_A mol:protein length:375 PROTEIN R2 OF RIBONUCLEOTIDE REDUCTASE  ali model follow..  9  32.......................................................KYDIFEKLIEKQLSFFW------------------------RPEEVDVSRDRIDYQALPEHEKHIFISNLKYQTLLDSIQGRSNVALLPLISIPELETWVETWAFSETIHSRSFTHIIRNIVNDPSVV-------DDIVTNEQIQKRAEGISSYYDEKKKLYLCLMSVNALEAIRYYVSFACSFAFAERELMEGNAKIIRLIARDAALHLTGTQHMLNLLRSGADDYDLFVQAAQQEKDWADYLFRDGSMIGLNKDILCQYVEYITNIRMQAVGL 321
56 -16.0001mrr_A mol:protein length:375 RIBONUCLEOTIDE REDUCTASE R1 PROTEIN  ali model follow..  8  32.......................................................KYDIFEKLIEKQLSFFW------------------------RPEEVDVSRDRIDYQALPEHEKHIFISNLKYQTLLDSIQGRSNVALLPLISIPELETWVETWAFSETIHSRSYTHIIRNIVNDPSVV-------DDIVTNEQIQKRAEGISSYYDEKKKLYLCLMSVNALEAIRFYVSFACSFAFAERELMEGNAKIIRLIARDEALHLTGTQHMLNLLRSGADDKQECYDLFVQAAQQEKDWADYLFRDGSMIGLNKDILCQYVEIRMQAVGL 321
57 -15.9001pj0_A mol:protein length:375 Ribonucleoside-diphosphate reductase 1 beta chain  ali model follow..  8  32.......................................................KYDIFEKLIEKQLSFFF------------------------RPEEVDVSRDRIDYQALPEHEKHIFISNLKYQTLLESIQGRSNVALLPLISIPELETWVETWAFSETIHSRSYTHIIRNIVNDPSVV-------DDIVTNEQIQKRAEGISSYYDEKKKLYLCLMSVNALEAIRFYVSFACSFAFAERELMEGNAKIIRLIARDEALHLTGTQHMLNLLRSGADDKQECYDLFVQAAQQEKDWADYLFRDGSMIGLNKDILCQYVEIRMQAVGL 321
58 -15.0003ez0_A mol:protein length:225 uncharacterized protein with ferritin-like fold  ali model follow..  9  10..................................................................................................................ARYNRFVADLFGMMAYGELSAFERFSADARYSPTLHDRAVLGRIAVVEFRHYELVSARLEAMGIDAED---------------AMLPFQAAVDYFTRPADWYESLMKAYVID-------VSADFYRAISRYVDAGTRDVIEQIQASDETTEVLRERLRSALADDPRLASRLALWGRRLLGEALTQAQRVSYE-ELVSGLIAGLAEKHSKRMTQLGL 223
59 -14.4004r42_A mol:protein length:236 Alr3090 protein  ali model follow..  6  18.................................................................................................................NPRFAQLLLEQFGG-ATGELSAALQYWVQSFHVENAGIKDMLQDIAIEEFSHLEMVGKLIEAHTKNVDQTEAYKSTLFA-GPHFLDSQGNAWTASYLNEGGDVVRDLRANIAAE------ARQTYEELIKLSPDEGTKQTLVHLLTREISHTQMFMKALDSLGKL.................................................... 180
60 -13.3005olk_A mol:protein length:430 Ribonucleoside-diphosphate reductase, beta subunit 1  ali model follow..  6  146........................................................................................................DIQDFKTGLSEVERSAIKNTMLAISQIEVAVKTFWGDVHHRLPKPEIAAVGATFAESEVRHHDAYSHLLEILGLNEEFKELKKKPVIMKRVHYLETSLKHAKSD--DDREYTESILLFALFIEHVSLFSQFLIIMAFNKHKN-KGISNAVEATSKEEQIHGDFGVDIINIIKKENPENNLIKEMCLNSFEAESKVVDWIFEKGELDFLPKAVINEFLKKSLEAIGL 380
61 -13.0002uw1_A mol:protein length:338 PLASTID DELTA4 MULTIFUNCTIONAL ACYL-ACYL CARRIER PROTEIN DESATURASE  ali model follow..  11  2.............................................................QVTHSMPPQKLEIFKSLDDWARNNVLIKSVEKSWQPQDYLPDPVSDGFEEQVRKEIPDDYFVVLVGDMITEEALPTYMSMLNRCAEPSAWAMWTRAWTAEENRHGDLLNKYLYLSGRVDM------------------RKIEKTIQYLIGSGENSPYLGFIYTSFQERATFISHANTAKLAQHYGDKKLAHICGSIASDEKRHATAYTKIVEKLAEIDPDTTVIA............................................ 229
62 -12.5003sid_A mol:protein length:180 Symerythrin  ali model follow..  9  2.....................................................................................GLNYNQEDFMGLDRFFQDAVS-------HNNTDANAASSIEVEMYECDCMYPTFAEIARRSGQPEIGAMFDAIAKEEGMHAQLLTKLYSELEVKDSAETLEAKRLVSTIESQIDAVASDSRG--------LRRALETALEVETIESQKTYPAFAKLAAEQGNMEVATAFEAIVKSETKHANWVKRALENLLE..................................................... 178
63 -12.5001oq4_A mol:protein length:363 Acyl-[acyl-carrier protein] desaturase  ali model follow..  11  11.VENLKKPFMPPREVHVQVTHSMPPQKIEIFK------------------------------SLDNWAEENILVHLKPVEKCWQPQDFLPDPASDGFDEQVRELRERA--KEIPDDYFVVLVGDMIT----EEALPTYQTMLNTLASPTSWAIWTRAWTAEENRHGDLLNKYLYLSGRVDM------------------RQIEKTIQYLIGSG--SPYLGFIYTSFQERATFISHGNTARQAKEHGDIKLAQICGTIAADEKRHETAYTKIVEKLFEIDPDGTVLA............................................ 254
64 -12.0001j30_A mol:protein length:144 144aa long hypothetical rubrerythrin  ali model follow..  11  1............................................................................................................MKDLKGTKTAENLKQGFI----GESMANRRYLYFAKRADEEGYPEIAGLIAEGETAHAFGHLDFIRQGGLTDP------------ATDKPIGTLEQMIESAIAG--------------ETYEWTQMYPGFAKVAREEGFPEVAEWFETLARAEKSHAEKFQNVLKQLKGGT................................................... 144
65 -11.6002clb_A mol:protein length:188 DPS-LIKE PROTEIN  ali model follow..  10  23.....................................................................................................................IKKLVDKLVKATAAEFTTYTILRMHLTGMEGEGLKEIAEDARLEDRLHFELMTQRIYELGGGLPRDIRQLADISACSDAYLPENWKDPKE-----------ILKVLLEAEQCAIRTWKEVCD--MTYGKDPRTYDLAQRILQEEIEHEAWFLELLYGRPSGHFRRS............................................... 178
66 -11.5003dde_A mol:protein length:239 TENA/THI-4 protein, Domain of Unknown Function with a Heme Oxygenase-like Fold  ali model follow..  5  20.....................................................................................................SILTNSPFIHEVLDG-KALYAIYMTETYHYTKHNAKNQALVGIMGKPGKYLSFCFHHAHEEAGHELMALSDIASIGFDREDVLSSKPL-------PATETLIAYLYWISATGNPVQ-RLGYSYWAENVYGYIDPVLKAIQSTLDLTPQSMKFFIAHSKIDAKHAEEVNEMLHEVCKTQEDVDSVVAVMENSLVLTARILDDVWKEYQLFQSGASDRYAFLRD....... 237
67 -11.4004di0_A mol:protein length:144 Rubrerythrin  ali model follow..  8  3..........................................................................................................GSMAQLKGSKTEENLKYAFA----GESQANRRYLYFASKADVNDIAALFRSTAEGETGHAHGHLEYLEAVGDPATGLPFGTSRQN----------------------------LQSAIAGETHEYTDMYPGMAKTARDEGFEEIANWFETLAKAERSHANRYTKALDGLVD..................................................... 144
68 -10.9002fzf_A mol:protein length:175 hypothetical protein  ali model follow..  7  21........................................................................................................................LEELLGMAIKAEIGAREFYKSLAEKIKIEALKEKINWLAEEEKKHEALLRKLYSQMFPGKEVVFPKEHIGPE-----------QPVARELEKVQDIIDLIRWAMKAEEIAAEF----YLKLEEMVKEEEKKRLMRYLADMERGHYYTLRAEYELLLNWEM.................................................. 166
69 -10.7001nf4_A mol:protein length:179 bacterioferritin  ali model follow..  14  1.............................................................................................................MAGNREDRKAKVIEVLNKARAMELHAIMNQHYSLDDMDYGELAANMKLIAIDEMRHAENFAERIKELGGEPTTQKEGKVV--------TGQAVPVIYES--------------DADQEDATIEA-YSQFLKVCKEQGDIVTARLFERIIEEEQAHLTYYENIGSHIKNLGDT................................................. 152
70 -10.5002qqy_A mol:protein length:149 Sigma B operon  ali model follow..  9  8.....................................................................................................................VKELIEGLNEDLAGEYSAINHNAATVSGIYRQVLKPFFESEISDEQGHALYLAEKIKTLGGT------------------------TTIPLRVKQAEDVREMLEYARQSEYETIKR-YEKRKEQAANLNMTELVVKLEDMIADETNHMEELDRLLNDK....................................................... 144
71 -10.5003qb9_A mol:protein length:174 Bacterioferritin  ali model follow..  13  1................................................................................................................MGMQGDPDVLRLLNEQLTSELTAIFLHSKMQDNWGFTELAAHTRAESFDEMRHAEEITDRILLLDGLPNYQRIGSLR--------IGQTLREQFEA--------------DLAIEYDVLN-RLKPGIVMCREKQDTTSAVLLEKIVADEEEHIDYLETQLELM....................................................... 143
72 -10.3005zur_A mol:protein length:158 Bacterioferritin  ali model follow..  13  5......................................................................................................................KTVIQFLNKQLTNELTAIFLHARMLNHWGFDKLGKHEYEESIGEMKHADRLIARIFMLDG---------------------LPNLQDLHKLLIGED-VPELLACDLKLEQAAHA-TVREAIAHCESVRDYVSRDLFQDILDDTEEHIDYLETQIDLI....................................................... 141
73 -10.2003gvy_A mol:protein length:161 Bacterioferritin  ali model follow..  10  5......................................................................................................................AKVIEYLNAALRSELTAVWLHYRLQEDWGFGSIAHKSRKESIEEMHHADKLIQRIIFLGGHPN---------QRLNPLRIGQTLRETLDA--------------DLAAEHDARTL-YIEARDHCEKVRDYPSKMLFEELIADEEGHIDYLETQIDLM....................................................... 141
74 -10.2004wwj_A mol:protein length:263 TENA/THI-4 family protein  ali model follow..  6  2.............................................................................PMIDTFSRTGPLMQQLIQDCSESKRRVVEHELYQRMRDN-AKVMRQYLIGGWPVVEQFALYMAQNLTKTRFARARRWLMRNIRVELNHADYWVHWSRAHGVTLEDLQAQQVP-------PELHALSHWCWHTSSADSLIVAIAATNYAIEGATGEWSALVCSNGIYAAARKRAMKWLKMHAQYDDAHPWEALEIIVTLAGLNPTKALQAELRQAICKSYDYMYLFLERCMQQEKTAVTRERLALAE....... 262
75 -10.2001bcf_A mol:protein length:158 BACTERIOFERRITIN  ali model follow..  13  5......................................................................................................................TKVINYLNKLLGNELVAIFLHARMFKNWGLKRLNDVEYHESIDEMKHADRYIERILFLEG---------------------LPNLQDLGKLNIGEDVEE-MLRSDLALELDGAK-NLREAIGYADSVHDYVSRDMMIEILRDEEGHIDWLETELDLI....................................................... 141
FFAS is supported by the NIH grant R01-GM087218-01
1 4 6 8 3 9   jobs submitted since Jan 1, 2011
Comments and questions to: webmaster
Selected papers from Godzik Lab
Ying Zhang, Ines Thiele, Dana Weekes, Zhanwen Li, Lukasz Jaroszewski, Krzysztof Ginalski, Ashley Deacon, John Wooley, Scott Lesley, Ian Wilson, Bernhard Palsson, Andrei Osterman, Adam Godzik. Three-Dimensional Structural View of the Central Metabolic Network of Thermotoga maritima. Science. 2009 Sep 18;325(5947):1544-9.

Mayya Sedova, Mallika Iyer, Zhanwen Li, Lukasz Jaroszewski, Kai W Post, Thomas Hrabe, Eduard Porta-Pardo, Adam Godzik Cancer3D 2.0:: interactive analysis of 3D patterns of cancer mutations in cancer subsets. Nucleic Acids Research, gky1098 2018; Published on November 8 2018.

Bourne PE, Allerston CK, Krebs W, Li W, Shindyalov IN, Godzik A.,Friedberg I, Liu T, Wild D, Hwang S, Ghahramani Z, Chen L, Westbrook J. The status of structural genomics defined through the analysis of current targets and structures. Pac Symp Biocomput. 2004;:375-86.